JANNEY DANIEL — SEC insider filings
SEC reporting owner CIK 1198325. 24 insider filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2020-08-07 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 631,250 shares, $4,884,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 43 legs across 11 filings — 344,305 shares, $45,555,677 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 100,000 shares @ $70.50 ($7,050,000) in Krystal Biotech, Inc., filed 2021-12-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | Director | 14 | — | 35 legs · 296,964 sh · $39,886,541 | 10 |
| Allakos Inc. (ALLK) | Director | 8 | 1 leg · 475,000 sh · $2,384,500 | 8 legs · 47,341 sh · $5,669,136 | 3 |
| Tyra Biosciences, Inc. (TYRA) | 10% owner | 1 | 1 leg · 156,250 sh · $2,500,000 | — | 3 |
| Esperion Therapeutics, Inc. (ESPR) | Director | 1 | — | — | 1 |
Insider filings — JANNEY DANIEL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 9,430 @ $275.45 · Sale (S): 2,373 @ $276.17 | EDGAR |
| 2026-02-26 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 37,895 @ $2.46 · Sale (S): 569 @ $262.91 · Sale (S): 1,733 @ $264.12 · Sale (S): 3,557 @ $265.08 · Sale (S): 8,986 @ $266.18 · Sale (S): 11,673 @ $266.97 · +16 more | EDGAR |
| 2025-06-30 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-07-03 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 4,604 @ $127.96 · Sale (S): 1,073 @ $129.02 · Sale (S): 5,388 @ $128.73 · Sale (S): 5,000 @ $127.96 · Sale (S): 10,000 @ $127.96 · Sale (S): 5,000 @ $127.86 · +3 more | EDGAR |
| 2023-05-30 | 4 | Allakos Inc. (ALLK) | Grant/award (A): 86,762 (derivative) @ $0 | EDGAR |
| 2023-05-23 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 50,000 @ $95.02 | EDGAR |
| 2023-05-11 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 17,100 @ $90.74 | EDGAR |
| 2023-04-21 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 7,900 @ $90.32 | EDGAR |
| 2022-09-23 | 4 | Allakos Inc. (ALLK) | Purchase (P): 475,000 @ $5.02 | EDGAR |
| 2022-07-01 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Allakos Inc. (ALLK) | Grant/award (A): 99,590 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 100,000 @ $70.50 | EDGAR |
| 2021-10-14 | 4 | Allakos Inc. (ALLK) | Grant/award (A): 7,700 (derivative) @ $0 | EDGAR |
| 2021-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) jointly with Alta Partners NextGen Fund II Management, LLC, Alta Partners NextGen Fund II, L.P., Hudson Peter A | Conversion (C): 3,811,117 · Purchase (P): 156,250 @ $16 · Conversion (C): 1,212,122 (derivative) @ $0 · Conversion (C): 255,160 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
| 2021-05-28 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 12,376 @ $0 | EDGAR |
| 2021-03-30 | 4 | Allakos Inc. (ALLK) | Sale (S): 14,808 @ $115.01 · Sale (S): 2,500 @ $116.09 | EDGAR |
| 2021-03-24 | 4 | Allakos Inc. (ALLK) | Sale (S): 9,030 @ $119.46 · Sale (S): 4,118 @ $120.22 | EDGAR |
| 2021-03-16 | 4 | Allakos Inc. (ALLK) | Sale (S): 4,071 @ $124.18 · Sale (S): 6,708 @ $124.56 | EDGAR |
| 2021-03-11 | 4 | Allakos Inc. (ALLK) | Sale (S): 100 @ $125 · Sale (S): 6,006 @ $124.62 | EDGAR |
| 2020-08-07 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 6,800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1198325 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs